Most of the alterations with confirmed somatic origin resulted in premature termination outside of the regions that are expected to evade nonsense mediated mRNA decay [26] and, therefore, are expected to result in loss of function, which is typical for the spectrum of BAP1 alterations in cancer. The gene discussed is BAP1; the disease is cancer.